Progression of liver cirrhosis to HCC: an application of hidden Markov model. - Wikidata - wikimedia - TriplyDB

Progression of liver cirrhosis to HCC: an application of hidden Markov model.

Progression of liver cirrhosis to HCC: an application of hidden Markov model.

http://www.wikidata.org/entity/Q33860546

about

From Data to Improved Decisions: Operations Research in Healthcare Delivery.Hepatocellular carcinoma: focus on different aspects of management Parameter estimates for invasive breast cancer progression in the Canadian National Breast Screening Study Efficient Learning of Continuous-Time Hidden Markov Models for Disease Progression Processing of miR17-92 Cluster in Hepatic Stellate Cells Promotes Hepatic Fibrogenesis During Alcohol-Induced Injury.Infective Endocarditis and Cancer Risk: A Population-Based Cohort Study.Nonalcoholic Cirrhosis Increased Risk of Digestive Tract Malignancies: A Population-Based Cohort Study.Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?

P2860

Q30252590-612C069C-60E0-424F-AD44-93C9A01F6C5D Q35986436-FFE2368F-9FE4-4DC0-B976-E49A83695481 Q36671878-E861C4B6-24BD-49CD-BE56-C8E99611EE30 Q36719092-007212BE-F41C-4E63-B75C-CDB0DB853C3A Q37059261-A0EA90E5-4A7B-48FA-B843-A87C492DEC0D Q37205492-F6AD0056-1D3E-43BC-B0B9-F954EAC44917 Q37225908-04E20641-48D4-4839-A316-C57B7A7AFD46 Q40707324-2DC06BD4-002D-4073-8591-DA88C4810E88

P2860

Progression of liver cirrhosis to HCC: an application of hidden Markov model.

http://www.wikidata.org/entity/Q33860546

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Progression of liver cirrhosis to HCC: an application of hidden Markov model.

@ast

Progression of liver cirrhosis to HCC: an application of hidden Markov model.

@en

type

label

Progression of liver cirrhosis to HCC: an application of hidden Markov model.

@ast

Progression of liver cirrhosis to HCC: an application of hidden Markov model.

@en

prefLabel

Progression of liver cirrhosis to HCC: an application of hidden Markov model.

@ast

Progression of liver cirrhosis to HCC: an application of hidden Markov model.

@en

P1433

Q33860546-24FF0D97-114F-420B-B6CB-0BA5C25810DC

P1476

Q33860546-77BA75CC-5DDA-4519-B424-CE21F4689C8D

P2860

Q33860546-1CB2A06D-FCF5-4D4B-AB1A-CE0F6B73D578

Q33860546-30C3F1A4-2B71-4221-BC28-A3B366BA6CC4

Q33860546-3836207B-C3CF-4875-846B-5256537544AB

Q33860546-43FB98DD-2785-4520-B520-909A9D3F61AE

Q33860546-462D4F71-9981-46E7-8F15-0D12241585D9

Q33860546-47C8AC4D-A36F-4506-BB49-C624F5CBBBC1

Q33860546-48B9F294-3C3E-400D-A976-287DB62C0003

Q33860546-4D28D365-5233-42A7-A9D1-37F45C1638D6

Q33860546-6C0D63CA-2B8E-4180-9C28-3C253DA39E21

Q33860546-709A5AE7-8643-443D-9B5A-92DEDA1F6866

P2888

Q33860546-B212CC3C-3734-4E83-9942-DAF1783650CC

P304

Q33860546-376E945D-8192-4A85-8ACB-7033A30EF7AB

P31

Q33860546-1E01786D-14DA-44B6-A3FA-6443AD9387BA

P356

Q33860546-70186389-6FE5-4A6E-8B73-90C76DB9CB14

P478

Q33860546-4EBB7D40-2951-4EC0-9A75-1C60B6934BB4

P50

Q33860546-76614DE2-8363-485B-BBEA-DE5891B225DB

Q33860546-B997C3AC-E3DF-47D7-AA93-FEF974207D61

Q33860546-CEE8F6E6-1371-4B31-B80D-D5783D63A6D5

P577

Q33860546-FD80F6F7-F3BF-4BCF-8348-8072D57406A0

P5875

Q33860546-91B1FFB5-07DB-4D4C-A21F-4DEBC5CD252A

P6179

Q33860546-6696CE94-A0E3-4681-85BF-62EA0DAD05FF

P698

Q33860546-5F4FB40C-DE04-44F8-AC26-E912D70F3B13

P921

Q33860546-4B0B11D9-5FA8-41A8-85A3-D72E0818B436

P932

Q33860546-D21BD16C-A5B8-4D3D-BA46-6E8B4F289DAB

P356

1471-2288-11-38

P1433

BMC Medical Research Methodology

P1476

Progression of liver cirrhosis to HCC: an application of hidden Markov model.

@en

P2860

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

The analysis of hospital infection data using hidden Markov models.

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults.

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.

Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance.

Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death.

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

P2888

1471-2288-11-38

P304

38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2288-11-38

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Paolo Trerotoli

Gabriella Serio

Nicola Bartolomeo

P577

2011-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50986620

http://www.w3.org/2001/XMLSchema#string

P6179

1006298504

http://www.w3.org/2001/XMLSchema#string

P698

21457586

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

P932

3087702

http://www.w3.org/2001/XMLSchema#string